ClinicalTrials.gg
CompletedNCT07946419Updated Nov 18, 2026

Evaluation of a Structured Nurse-led Patient Education and Tele-monitoring to Review Asthma Patients With Suboptimal Control: A Pilot Study

An interventional study of Structured nurse-led patient education and tele-monitoring in Asthma Attack, Asthma Chronic and Asthma Acute, sponsored by SingHealth Polyclinics. Completed at 3 sites in Singapore. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by SingHealth Polyclinics · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 2 years 8 months after the study started (first participant enrolled Feb 2024, registered Nov 2026).
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
113
Allocation
Randomized
Ages
21 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Asthma with a site in Singapore — 3 open to participants now, 3 under way, 1 of them phase 3. Asthma · Singapore.

Enrollment
16th of 19
113 · median 253
Started
2024
with 1 other
No phase
5 of 25
1 open now
Registered
25th of 25
by date
Lead sponsor
2 of 25
SingHealth Polyclinics

Among the 25 studies in Asthma with a site in Singapore, this one is the 16th largest by enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2024, is one of 5 with no phase, and was the 25th registered.

Asthma

4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.

Browse Asthma studies →

Open to participants now

3 of the 25 studies in Asthma with a site in Singapore are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.

This study: 21 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Asthma with a site in Singapore, or all of them as a file.
02

Study summary

The aim of this mixed method study is to evaluate a structured nurse-led patient education and tele-monitoring for asthma patients with suboptimal control.

Read the detailed description

The aims of the study are:

  1. To determine the preliminary effectiveness of a structured nurse-led patient education followed by tele-monitoring in within 1-month and 3-month time for:

    i. Improvement of GINA scores

    ii. The frequency of asthma exacerbation

    iii. The frequency of asthma related visit to emergency department and hospitalization

  2. To assess the feasibility, benefits, and limitations of the intervention through a semi structured interview.

Patients with no asthma exacerbation will be randomly assigned to either control group or intervention group, with total sample size of 84. Forty participants with exacerbation requiring rescue therapy will also be recruited from the three polyclinics involved in this study. All patients with asthma exacerbation will receive the intervention in accordance with the current standard care. All patients who received the structured asthma counselling and the tele-follow-up will be invited to join a face-to-face qualitative interviewto provide feedback on improving the intervention,which is non-compulsory.

03

Conditions studied

  • Asthma Attack
  • Asthma Chronic
  • Asthma Acute

Browse trials for

Keywords

  • suboptimal asthma
04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult (age >= 21)
  • Asthma patients with GINA >=1 on the day of clinic visit
  • Able to use Zoom platform for video consultation

Exclusion criteria

Exclusion Criteria:

  • Present with asthma exacerbation on the day of clinic who opt for phone call follow up in 3-5 days for the feedback interview.
  • Patients with on-going COVID infection, Pneumonia, Influenza
  • Patients with no capacity to give
  • Prefer not to follow up at SingHealth Polyclinics
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
113 participants (actual)

Study arms

  • Experimental
    Interventional

    The intervention consists of one session of face-to-face nurse asthma counselling at initial clinic visit and one session of video consultation by nurse in 3-5 days' post clinic visit on top of routine care. Nurses will conduct one face-to-face asthma education session using the "Asthma Health Education Slides" which is approved by SingHealth Polyclinic Patient Education \& Respiratory Committee in April 2022 and available in the SingHealth Polyclinic intranet. The education is expected to take 30minutes. Nurses will conduct a video followup with participants 3 to 5 days later. It is estimated to take about 10-15 minutes. During the followup, nurses will assess and give advice on further asthma management based on participants' current asthma condition, if any ongoing asthma symptoms.Nurses will reinforce on compliance with Asthma Action Plan (AAP).Nurses will also ask the participants if they have any further questions, and to clarify as needed.

    Other: Structured nurse-led patient education and tele-monitoring

  • Active comparator
    Control

    Participants in the control group will receive routine care which is a follow up by clinic doctors in four weeks and will not receive structured asthma counselling by nurses.

    Other: Structured nurse-led patient education and tele-monitoring

Interventions

  • OtherStructured nurse-led patient education and tele-monitoring

    Patient education by nurses with video follow-up

06

What researchers measure

Primary outcomes

  1. Improvement of GINA scores

    Time frame: 2-4week, 3-month

  2. The frequency of asthma exacerbation

    Time frame: 2-4week, 3-month

  3. The frequency of asthma related visit to emergency department and hospitalization

    Time frame: 2-4week, 3-month

07

Study locations

3 sites
  • Singhealth Polyclinics - Outram
    Singapore, Singapore 168937, Singapore
  • SingHealth Polyclinics - Bedok
    Singapore, Singapore 469662, Singapore
  • Singhealth Polyclinics - Pasir Ris
    Singapore, Singapore 519457, Singapore
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Mar 2025, 13 months.

Of 601 non-industry interventional studies with no phase under Asthma, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's 13 months is below that.

Counting every sponsor, half of 651 studies reached it within 23 months; a quarter within 10 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartActual
Feb 16, 2024
Primary completionActual
Mar 26, 2025
CompletionActual
Mar 26, 2025
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946419
Lead sponsor
SingHealth Polyclinics
Responsible party
Sponsor
First posted
Nov 18, 2026
Start date
Feb 16, 2024
Primary completion
Mar 26, 2025
Completion
Mar 26, 2025
Last update
Nov 18, 2026

Study contacts

Kwee Lian Tham
principal investigator · SingHealth Polyclinics

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion